Seres Therapeutics, Inc. (MCRB) Q4 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Seres Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.094 My name is Kate and I will be your conference operator today. 00:00:03.094 -- 00:00:09.217 At this time, I would like to welcome everyone to the Q4 2024 00:00:09.299 -- 00:00:14.244 series Therapeutics Incorporated Earnings Conference call. 00:00:14.244 -- 00:00:18.087 All lines have been placed on mute to prevent any background noise. 00:00:18.087 -- 00:00:22.331 After the speaker's remarks, there will be a question and answer session. 00:00:22.331 -- 00:00:26.715 If you would like to ask a question during this time, simply press star followed with 00:00:26.715 -- 00:00:31.093 the number one on your telephone keypad. If you would like to withdraw your question, 00:00:31.093 -- 00:00:36.278 press star 1 again. Thank you. I would now like to turn the call over to Carlo Tanzi 00:00:36.278 -- 00:00:40.282 of Investor Relations. Please go ahead. 00:00:40.282 -- 00:00:44.286 Thank you and good morning. Our press release with the company's fourth quarter and full 00:00:44.286 -- 00:00:48.870 year 2024 financial results and business updates became available at 7 a.m. 00:00:48.870 -- 00:00:53.295 Eastern Time this morning and can be found on the Investors & News section of the company's 00:00:53.295 -- 00:00:58.030 website. The company has also posted an updated corporate presentation to the website. 00:00:58.030 -- 00:01:02.034 I'd like to remind you that we'll be making forward-looking statements, including statements 00:01:02.034 -- 00:01:06.438 about the timing and results of our clinical studies and data readouts, future product 00:01:06.438 -- 00:01:11.544 candidates, clinical development plans and commercial opportunities, interactions 00:01:11.544 -- 00:01:16.589 with regulatory agencies, receipt of future payments related to the v...